Roche’s severe COVID-19 test scores FDA approval

Some COVID-19 patients can develop a severe inflammatory response called a cytokine storm, which can be deadly and pose a high risk of intubation via mechanical ventilation.

As a result, the FDA granted emergency authorization to a blood test from Roche (OTCQX:RHHBY), called Elecsys IL-6, which can pinpoint those most at-risk people early by measuring levels of interleukin 6 in the blood.

Roche also makes one of the most accurate serology tests, which hunts for coronavirus antibodies to identify past infection.

https://seekingalpha.com/news/3580297-roches-severe-covidminus-19-test-scores-fda-approval